PRKAA1 and steatosis: Furthermore, dihydromyricetin can alleviate inflammation-induced insulin resistance through the phospholipase C (PLC)–CaMKK–AMPK signalling pathway [100], and vaccarin can alleviate insulin resistance and steatosis by activating the AMPK signalling pathway [113].